May trade under 0.20 today its seems , which is 1 cent old sp , over $1.5 million receivables , orphan drug application in March quarter means nothing to the market , seems just no confidence in the current team , lead by the same CEO since 2007 .
Cellmid really should at least try a different approach , anything is worth a try .
Investors are really being hit extremely hard here .
- Forums
- ASX - By Stock
- AN1
- Ann: Midkine Symposium Munich
Ann: Midkine Symposium Munich, page-74
-
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AN1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AN1 (ASX) Chart |
Day chart unavailable
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online